SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox

If approved, TPOXX would be the first treatment for smallpox NEW YORK, Feb. 07, 2018 -- (Healthcare Sales & Marketing Network) -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a health security company specializing in the development and commercializat... Biopharmaceuticals, FDA SIGA Technologies, TPOXX, tecovirimat, smallpox
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news